References
Chan JK, Kwong YL (2010) Common misdiagnoses in lymphomas and avoidance strategies. Lancet Oncol 6:579–588
Oliveira JL, Grogg KL, Macon WR, Dogan A, Feldman AL (2012) Clinicopathologic features of B-cell lineage neoplasms with aberrant expression of CD3: a study of 21 cases. Am J Surg Pathol 36(9):1364–1370
Tsuyama N, Ennishi D, Yokoyama M, Baba S, Asaka R, Mishima Y, Terui Y, Hatake K, Takeuchi K (2017) Clinical and prognostic significance of aberrant T-cell marker expression in 225 cases of de novo diffuse large B-cell lymphoma and 276 cases of other B-cell lymphomas. Oncotarget 8(20):33487–33500
Pan Z, Chen M, Zhang Q, Wang E, Yin L, Xu Y, Huang Q, Yuan Y, Zhang X, Zheng G, Yuan J (2018) CD3-positive plasmablastic B-cell neoplasms: a diagnostic pitfall. Mod Pathol 31(5):718–731
Campo E, Stein H, Harris NL (2017) Plasmablastic lymphoma. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Arber DA, Hasserjian RP, Le Beau MM, Orazi A, Siebert R (eds) WHO classification of tumours of haematopoietic and lymphoid tissues. International Agency for Research on Cancer, Lyon, pp 321–322
Morscio J, Dierickx D, Nijs J, Verhoef G, Bittoun E, Vanoeteren X, Wlodarska I, Sagaert X, Tousseyn T (2014) Clinicopathologic comparison of plasmablastic lymphoma in HIV-positive, immunocompetent, and posttransplant patients: single-center series of 25 cases and meta-analysis of 277 reported cases. Am J Surg Pathol 38(7):875–886
Tchernonog E, Faurie P, Coppo P, Monjanel H, Bonnet A, Algarte Génin M, Mercier M, Dupuis J, Bijou F, Herbaux C, Delmer A, Fabiani B, Besson C, Le Gouill S, Gyan E, Laurent C, Ghesquieres H, Cartron G (2017) Clinical characteristics and prognostic factors of plasmablastic lymphoma patients: analysis of 135 patients from the LYSA group. Ann Oncol 28(4):843–848
Chen BJ, Chuang SS (2020) Lymphoid neoplasms with plasmablastic differentiation: a comprehensive review and diagnostic approaches. Adv Anat Pathol 27(2):61–74
Gaulard P, Swerdlow SH, Harris NL, Sundstrom C, Jaffe ES (2017) Other iatrogenic immunodeficiency-associated lymphoproliferative disorders. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Arber DA, Hasserjian RP, Le Beau MM, Orazi A, Siebert R (eds) WHO classification of tumours of haematopoietic and lymphoid tissues. International Agency for Research on Cancer, Lyon, pp 462–464
Chan TSY, Lee E, Khong PL, Tse EWC, Kwong YL (2018) Positron emission tomography computed tomography features of monomorphic epitheliotropic intestinal T-cell lymphoma. Hematology 23(1):10–16
Acknowledgments
The authors have no acknowledgement to make
Author information
Authors and Affiliations
Contributions
H. Gill: treated the patient and wrote and approved the manuscript
R. Au-Yeung: performed the histopathologic diagnosis and wrote and approved the manuscript
F. Loong: performed the histopathologic diagnosis and approved the manuscript
Y.L. Kwong: treated the patient and wrote and approved the manuscript
Corresponding author
Ethics declarations
Conflict of interests
The authors declare that they have no conflict of interest.
Informed consent
The patient gave informed consent to treatment.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Gill, H., Au-Yeung, R., Loong, F. et al. CD3+CD4+ lymphoid neoplasm: diagnostic clues for plasmablastic lymphoma instead of peripheral T-cell lymphoma. Ann Hematol 101, 223–226 (2022). https://doi.org/10.1007/s00277-021-04415-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-021-04415-0